ArticleFrontiers in oncology2022

Case report: Long-lasting SARS-CoV-2 infection with post-COVID-19 condition in two patients with chronic lymphocytic leukemia: The emerging therapeutic role of casirivimab/imdevimab.

Laura Ballotta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.